The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
insulin degludec · Powder
2 marketed package NDCs · 2 active manufacturers
Most dispensed: 200 U/mL · Injection, Solution · #3 syringe, plastics/carton / 3 ml in 1 syringe, plastic · 100 U/mL · Injection, Solution · #1 vial, glass/carton / 10 ml in 1 vial, glass · 100 U/mL · Injection, Solution · #5 syringe, plastics/carton / 3 ml in 1 syringe, plastic
What changed in the last 90 days
Every detected change for insulin degludec, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- TresibaAug 19, 2026Price downNADAC $9.02718 → $9.02082 per unit (-0.07%)
- TresibaAug 19, 2026Price downNADAC $9.03903 → $9.03696 per unit (-0.02%)
- TresibaAug 19, 2026Price upNADAC $18.06134 → $18.07211 per unit (+0.06%)
- TresibaJul 22, 2026Price upNADAC $9.02431 → $9.02718 per unit (+0.03%)
- TresibaJul 22, 2026Price downNADAC $18.07117 → $18.06134 per unit (-0.05%)
- TresibaJul 22, 2026Price downNADAC $9.04254 → $9.03903 per unit (-0.04%)
Same drug class
Other molecules FDA puts in Insulin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- attention deficit mild drops· 1 maker
- attention deficit severe drops· 1 maker
- dna insulin drops· 1 maker
- insulin aspart injection· 1 maker
- insulin aspart-fsan· 1 maker
- insulin aspart-xjhz· 1 maker
- insulin degludec and liraglutide· 1 maker
- insulin glargine and lixisenatide· 1 maker
- insulin glargine-aldy· 1 maker
- insulin glulisine· 1 maker
- pancreas db liquescence· 1 maker
- insulin· 2 makers
Common questions
- Is Insulin degludec in shortage right now?
- No. FDA does not currently list Insulin degludec in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Insulin degludec?
- 5 companies have marketed Insulin degludec in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Insulin degludec cost?
- The typical pharmacy pays about $11.37 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.